Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

Clinical trial NCT03962049 · COMPLETED

Trial details

NCT number: NCT03962049
Sponsor: ObsEva SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Healthy Participants

Start date: 2019-05-15
Primary completion: 2019-10-23
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.